<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>43 Rectal Adjuvant Therapy | GI Surgical Oncology</title>
  <meta name="description" content="Orientation Manual for GI Surgical Oncology Service" />
  <meta name="generator" content="bookdown 0.28 and GitBook 2.6.7" />

  <meta property="og:title" content="43 Rectal Adjuvant Therapy | GI Surgical Oncology" />
  <meta property="og:type" content="book" />
  
  <meta property="og:description" content="Orientation Manual for GI Surgical Oncology Service" />
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="43 Rectal Adjuvant Therapy | GI Surgical Oncology" />
  
  <meta name="twitter:description" content="Orientation Manual for GI Surgical Oncology Service" />
  




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="120x120" href="images/icon120.png" />
  <link rel="shortcut icon" href="images/favicon.io" type="image/x-icon" />
<link rel="prev" href="rectal-cancer-surgery.html"/>
<link rel="next" href="soft-tissue-sarcomas.html"/>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.1.0/anchor-sections.css" rel="stylesheet" />
<link href="libs/anchor-sections-1.1.0/anchor-sections-hash.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.1.0/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li>GI Surgical Oncology</li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> Overview</a>
<ul>
<li class="chapter" data-level="1.1" data-path="index.html"><a href="index.html#absences"><i class="fa fa-check"></i><b>1.1</b> Absences</a></li>
<li class="chapter" data-level="1.2" data-path="index.html"><a href="index.html#communication"><i class="fa fa-check"></i><b>1.2</b> Communication</a></li>
<li class="chapter" data-level="1.3" data-path="index.html"><a href="index.html#medical-records"><i class="fa fa-check"></i><b>1.3</b> Medical Records</a></li>
<li class="chapter" data-level="1.4" data-path="index.html"><a href="index.html#operative-logs"><i class="fa fa-check"></i><b>1.4</b> Operative Logs</a></li>
<li class="chapter" data-level="1.5" data-path="index.html"><a href="index.html#case-assignment"><i class="fa fa-check"></i><b>1.5</b> Case Assignment</a></li>
<li class="chapter" data-level="1.6" data-path="index.html"><a href="index.html#clinic"><i class="fa fa-check"></i><b>1.6</b> Clinic</a></li>
<li class="chapter" data-level="1.7" data-path="index.html"><a href="index.html#work-hours"><i class="fa fa-check"></i><b>1.7</b> Work Hours</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html"><i class="fa fa-check"></i><b>2</b> CMC Inpatient</a>
<ul>
<li class="chapter" data-level="2.1" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#admissions"><i class="fa fa-check"></i><b>2.1</b> Admissions</a></li>
<li class="chapter" data-level="2.2" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#rounds"><i class="fa fa-check"></i><b>2.2</b> Rounds</a></li>
<li class="chapter" data-level="2.3" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#resident-epic-teams"><i class="fa fa-check"></i><b>2.3</b> Resident Epic teams:</a></li>
<li class="chapter" data-level="2.4" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#consults"><i class="fa fa-check"></i><b>2.4</b> Consults</a></li>
<li class="chapter" data-level="2.5" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#postop-clinic-appt"><i class="fa fa-check"></i><b>2.5</b> Postop Clinic Appt</a></li>
<li class="chapter" data-level="2.6" data-path="cmc-inpatient.html"><a href="cmc-inpatient.html#conferences"><i class="fa fa-check"></i><b>2.6</b> Conferences</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html"><i class="fa fa-check"></i><b>3</b> Pineville Inpatient</a>
<ul>
<li class="chapter" data-level="3.1" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#rounds-1"><i class="fa fa-check"></i><b>3.1</b> Rounds</a></li>
<li class="chapter" data-level="3.2" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#resident-epic-teams-1"><i class="fa fa-check"></i><b>3.2</b> Resident Epic teams:</a></li>
<li class="chapter" data-level="3.3" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#consults-1"><i class="fa fa-check"></i><b>3.3</b> Consults</a></li>
<li class="chapter" data-level="3.4" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#postop-clinic-appts"><i class="fa fa-check"></i><b>3.4</b> Postop Clinic Appts</a></li>
<li class="chapter" data-level="3.5" data-path="pineville-inpatient.html"><a href="pineville-inpatient.html#conferences-1"><i class="fa fa-check"></i><b>3.5</b> Conferences</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="rounds-2.html"><a href="rounds-2.html"><i class="fa fa-check"></i><b>4</b> Rounds</a></li>
<li class="chapter" data-level="5" data-path="progress-notes.html"><a href="progress-notes.html"><i class="fa fa-check"></i><b>5</b> Progress Notes</a></li>
<li class="chapter" data-level="6" data-path="discharges.html"><a href="discharges.html"><i class="fa fa-check"></i><b>6</b> Discharges</a></li>
<li class="chapter" data-level="7" data-path="education.html"><a href="education.html"><i class="fa fa-check"></i><b>7</b> Education</a>
<ul>
<li class="chapter" data-level="7.0.1" data-path="education.html"><a href="education.html#student-emr-notes-policy"><i class="fa fa-check"></i><b>7.0.1</b> Student EMR Notes Policy</a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="clinic-1.html"><a href="clinic-1.html"><i class="fa fa-check"></i><b>8</b> Clinic</a>
<ul>
<li class="chapter" data-level="8.1" data-path="clinic-1.html"><a href="clinic-1.html#salo-clinic"><i class="fa fa-check"></i><b>8.1</b> Salo Clinic</a></li>
</ul></li>
<li class="chapter" data-level="9" data-path="mie_postop.html"><a href="mie_postop.html"><i class="fa fa-check"></i><b>9</b> Postop Care after Esophagectomy</a>
<ul>
<li class="chapter" data-level="9.1" data-path="mie_postop.html"><a href="mie_postop.html#weaning-tube-feeds-in-diabetics"><i class="fa fa-check"></i><b>9.1</b> Weaning Tube Feeds in Diabetics</a></li>
</ul></li>
<li class="part"><span><b>Postoperative Care</b></span></li>
<li class="chapter" data-level="10" data-path="colectomy.html"><a href="colectomy.html"><i class="fa fa-check"></i><b>10</b> Colectomy</a></li>
<li class="chapter" data-level="11" data-path="lar-ileostomy.html"><a href="lar-ileostomy.html"><i class="fa fa-check"></i><b>11</b> LAR + Ileostomy</a></li>
<li class="chapter" data-level="12" data-path="abdominoperineal-resection.html"><a href="abdominoperineal-resection.html"><i class="fa fa-check"></i><b>12</b> Abdominoperineal Resection</a></li>
<li class="chapter" data-level="13" data-path="esophagectomy-postop.html"><a href="esophagectomy-postop.html"><i class="fa fa-check"></i><b>13</b> Esophagectomy Postop</a></li>
<li class="chapter" data-level="14" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html"><i class="fa fa-check"></i><b>14</b> Esophagectomy Ward</a>
<ul>
<li class="chapter" data-level="14.1" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#anti-hypertensives"><i class="fa fa-check"></i><b>14.1</b> Anti-Hypertensives</a></li>
<li class="chapter" data-level="14.2" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#chest-tubes"><i class="fa fa-check"></i><b>14.2</b> Chest tubes</a></li>
<li class="chapter" data-level="14.3" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#gi-medicines"><i class="fa fa-check"></i><b>14.3</b> GI Medicines</a></li>
<li class="chapter" data-level="14.4" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#leak_evaluation"><i class="fa fa-check"></i><b>14.4</b> Evaluation for leak</a>
<ul>
<li class="chapter" data-level="14.4.1" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#drain_amylase"><i class="fa fa-check"></i><b>14.4.1</b> Drain Amylase</a></li>
<li class="chapter" data-level="14.4.2" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#ct_esophagram"><i class="fa fa-check"></i><b>14.4.2</b> CT esophagram</a></li>
</ul></li>
<li class="chapter" data-level="14.5" data-path="esophagectomy-ward.html"><a href="esophagectomy-ward.html#anastomotic-leak-treatment"><i class="fa fa-check"></i><b>14.5</b> Anastomotic Leak Treatment</a></li>
</ul></li>
<li class="chapter" data-level="15" data-path="jejunostomy-feedings.html"><a href="jejunostomy-feedings.html"><i class="fa fa-check"></i><b>15</b> Jejunostomy Feedings</a>
<ul>
<li class="chapter" data-level="15.1" data-path="jejunostomy-feedings.html"><a href="jejunostomy-feedings.html#med-administration-via-j-tubes"><i class="fa fa-check"></i><b>15.1</b> Med Administration via J-Tubes</a></li>
<li class="chapter" data-level="15.2" data-path="jejunostomy-feedings.html"><a href="jejunostomy-feedings.html#occluded-jejunostomy-tubes"><i class="fa fa-check"></i><b>15.2</b> Occluded Jejunostomy Tubes</a></li>
<li class="chapter" data-level="15.3" data-path="jejunostomy-feedings.html"><a href="jejunostomy-feedings.html#jejunostomy_diabetes"><i class="fa fa-check"></i><b>15.3</b> Jejunostomy + Diabetes</a></li>
</ul></li>
<li class="part"><span><b>Hill OR</b></span></li>
<li class="chapter" data-level="16" data-path="colorectal-cases---hillsquires.html"><a href="colorectal-cases---hillsquires.html"><i class="fa fa-check"></i><b>16</b> Colorectal Cases - Hill/Squires</a></li>
<li class="part"><span><b>Salo OR</b></span></li>
<li class="chapter" data-level="17" data-path="cv_port_salo.html"><a href="cv_port_salo.html"><i class="fa fa-check"></i><b>17</b> CV Port (IJ) - Salo</a></li>
<li class="chapter" data-level="18" data-path="lap-jejunostomy.html"><a href="lap-jejunostomy.html"><i class="fa fa-check"></i><b>18</b> Lap Jejunostomy</a></li>
<li class="chapter" data-level="19" data-path="lap_gastrostomy_salo.html"><a href="lap_gastrostomy_salo.html"><i class="fa fa-check"></i><b>19</b> Lap Gastrostomy - Salo</a></li>
<li class="chapter" data-level="20" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html"><i class="fa fa-check"></i><b>20</b> Esophagectomy 1 Stage</a>
<ul>
<li class="chapter" data-level="20.1" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#indications"><i class="fa fa-check"></i><b>20.1</b> Indications</a></li>
<li class="chapter" data-level="20.2" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#room-prep"><i class="fa fa-check"></i><b>20.2</b> Room Prep</a>
<ul>
<li class="chapter" data-level="20.2.1" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#time-out"><i class="fa fa-check"></i><b>20.2.1</b> Time Out</a></li>
</ul></li>
<li class="chapter" data-level="20.3" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#gastric-mobilization"><i class="fa fa-check"></i><b>20.3</b> Gastric Mobilization</a>
<ul>
<li class="chapter" data-level="20.3.1" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#distal-mobilization"><i class="fa fa-check"></i><b>20.3.1</b> Distal mobilization</a></li>
<li class="chapter" data-level="20.3.2" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#left-gastric-artery"><i class="fa fa-check"></i><b>20.3.2</b> Left gastric artery</a></li>
<li class="chapter" data-level="20.3.3" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#mediastinal-dissection"><i class="fa fa-check"></i><b>20.3.3</b> Mediastinal dissection</a></li>
<li class="chapter" data-level="20.3.4" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#division-of-esophagus-four-phase"><i class="fa fa-check"></i><b>20.3.4</b> Division of Esophagus (Four-Phase)</a></li>
<li class="chapter" data-level="20.3.5" data-path="esophagectomy-1-stage.html"><a href="esophagectomy-1-stage.html#entry-into-right-chest"><i class="fa fa-check"></i><b>20.3.5</b> Entry into right chest</a></li>
</ul></li>
</ul></li>
<li class="part"><span><b>Esophageal Cancer</b></span></li>
<li class="chapter" data-level="21" data-path="EsoIntro.html"><a href="EsoIntro.html"><i class="fa fa-check"></i><b>21</b> Esophageal Overview</a></li>
<li class="chapter" data-level="22" data-path="staging.html"><a href="staging.html"><i class="fa fa-check"></i><b>22</b> Staging</a></li>
<li class="chapter" data-level="23" data-path="superficial.html"><a href="superficial.html"><i class="fa fa-check"></i><b>23</b> Superficial EsoCa</a>
<ul>
<li class="chapter" data-level="23.1" data-path="superficial.html"><a href="superficial.html#emr"><i class="fa fa-check"></i><b>23.1</b> Endscopic Mucosal Resection (EMR)</a></li>
</ul></li>
<li class="chapter" data-level="24" data-path="localized.html"><a href="localized.html"><i class="fa fa-check"></i><b>24</b> Localized EsoCa</a>
<ul>
<li class="chapter" data-level="24.1" data-path="localized.html"><a href="localized.html#t1b-tumors"><i class="fa fa-check"></i><b>24.1</b> T1b Tumors</a></li>
<li class="chapter" data-level="24.2" data-path="localized.html"><a href="localized.html#t2n0-tumors"><i class="fa fa-check"></i><b>24.2</b> T2N0 Tumors</a></li>
<li class="chapter" data-level="24.3" data-path="localized.html"><a href="localized.html#staging-of-t2n0-tumors"><i class="fa fa-check"></i><b>24.3</b> Staging of T2N0 Tumors</a></li>
</ul></li>
<li class="chapter" data-level="25" data-path="locally_advanced.html"><a href="locally_advanced.html"><i class="fa fa-check"></i><b>25</b> Locally Advanced EsoCa</a>
<ul>
<li class="chapter" data-level="25.1" data-path="locally_advanced.html"><a href="locally_advanced.html#trimodality"><i class="fa fa-check"></i><b>25.1</b> Trimodality Therapy</a>
<ul>
<li class="chapter" data-level="25.1.1" data-path="locally_advanced.html"><a href="locally_advanced.html#neoadjuvant-chemort-for-scca"><i class="fa fa-check"></i><b>25.1.1</b> Neoadjuvant chemoRT for SCCA</a></li>
<li class="chapter" data-level="25.1.2" data-path="locally_advanced.html"><a href="locally_advanced.html#neoadjuvant-chemotheraphy-followed-by-surgery"><i class="fa fa-check"></i><b>25.1.2</b> Neoadjuvant chemotheraphy followed by surgery</a></li>
</ul></li>
<li class="chapter" data-level="25.2" data-path="locally_advanced.html"><a href="locally_advanced.html#ge-junction"><i class="fa fa-check"></i><b>25.2</b> GE Junction</a></li>
<li class="chapter" data-level="25.3" data-path="locally_advanced.html"><a href="locally_advanced.html#induction-chemotherapy-followed-by-chemort"><i class="fa fa-check"></i><b>25.3</b> Induction chemotherapy followed by chemoRT</a></li>
<li class="chapter" data-level="25.4" data-path="locally_advanced.html"><a href="locally_advanced.html#postoperative-chemoradiation"><i class="fa fa-check"></i><b>25.4</b> Postoperative chemoradiation</a></li>
</ul></li>
<li class="chapter" data-level="26" data-path="eso_dcrt.html"><a href="eso_dcrt.html"><i class="fa fa-check"></i><b>26</b> Chemoradiation</a>
<ul>
<li class="chapter" data-level="26.1" data-path="eso_dcrt.html"><a href="eso_dcrt.html#phase-ii-studies"><i class="fa fa-check"></i><b>26.1</b> Phase II Studies</a></li>
<li class="chapter" data-level="26.2" data-path="eso_dcrt.html"><a href="eso_dcrt.html#chemort-vs-trimodality-therapy"><i class="fa fa-check"></i><b>26.2</b> ChemoRT vs Trimodality therapy</a></li>
</ul></li>
<li class="chapter" data-level="27" data-path="radiation.html"><a href="radiation.html"><i class="fa fa-check"></i><b>27</b> Radiation</a></li>
<li class="chapter" data-level="28" data-path="esophagectomy.html"><a href="esophagectomy.html"><i class="fa fa-check"></i><b>28</b> Esophagectomy</a>
<ul>
<li class="chapter" data-level="28.0.1" data-path="esophagectomy.html"><a href="esophagectomy.html#ge-junction-adenocarcinoma"><i class="fa fa-check"></i><b>28.0.1</b> GE Junction Adenocarcinoma</a></li>
<li class="chapter" data-level="28.0.2" data-path="esophagectomy.html"><a href="esophagectomy.html#preoperative-evaluation"><i class="fa fa-check"></i><b>28.0.2</b> Preoperative Evaluation</a></li>
<li class="chapter" data-level="28.1" data-path="esophagectomy.html"><a href="esophagectomy.html#minimally-invasive-esophagectomy"><i class="fa fa-check"></i><b>28.1</b> Minimally-invasive Esophagectomy</a></li>
<li class="chapter" data-level="28.2" data-path="esophagectomy.html"><a href="esophagectomy.html#early-recovery-pathways"><i class="fa fa-check"></i><b>28.2</b> Early Recovery Pathways</a></li>
<li class="chapter" data-level="28.3" data-path="esophagectomy.html"><a href="esophagectomy.html#salvage-esophagectomy"><i class="fa fa-check"></i><b>28.3</b> Salvage esophagectomy</a></li>
</ul></li>
<li class="chapter" data-level="29" data-path="eso_metastatic.html"><a href="eso_metastatic.html"><i class="fa fa-check"></i><b>29</b> Metastatic EsoCa</a>
<ul>
<li class="chapter" data-level="29.1" data-path="eso_metastatic.html"><a href="eso_metastatic.html#palliative-radiation"><i class="fa fa-check"></i><b>29.1</b> Palliative radiation</a></li>
<li class="chapter" data-level="29.2" data-path="eso_metastatic.html"><a href="eso_metastatic.html#chemoradiation-vs-chemotherapy-in-stage-iv"><i class="fa fa-check"></i><b>29.2</b> Chemoradiation vs chemotherapy in Stage IV</a></li>
<li class="chapter" data-level="29.3" data-path="eso_metastatic.html"><a href="eso_metastatic.html#stents-for-malignant-disease"><i class="fa fa-check"></i><b>29.3</b> Stents for malignant disease</a></li>
</ul></li>
<li class="chapter" data-level="30" data-path="eso_survivorship.html"><a href="eso_survivorship.html"><i class="fa fa-check"></i><b>30</b> Survivorship</a>
<ul>
<li class="chapter" data-level="30.1" data-path="eso_survivorship.html"><a href="eso_survivorship.html#nutritional-consequences-of-esophagectomy"><i class="fa fa-check"></i><b>30.1</b> Nutritional consequences of esophagectomy</a>
<ul>
<li class="chapter" data-level="30.1.1" data-path="eso_survivorship.html"><a href="eso_survivorship.html#vitamin-d-deficiency"><i class="fa fa-check"></i><b>30.1.1</b> Vitamin D deficiency</a></li>
</ul></li>
<li class="chapter" data-level="30.2" data-path="eso_survivorship.html"><a href="eso_survivorship.html#cardiac-toxicity-of-radiation"><i class="fa fa-check"></i><b>30.2</b> Cardiac toxicity of radiation</a></li>
<li class="chapter" data-level="30.3" data-path="eso_survivorship.html"><a href="eso_survivorship.html#eso_surveillance"><i class="fa fa-check"></i><b>30.3</b> Surveillance</a></li>
</ul></li>
<li class="part"><span><b>Gastric Cancer</b></span></li>
<li class="chapter" data-level="31" data-path="gastric-overview.html"><a href="gastric-overview.html"><i class="fa fa-check"></i><b>31</b> Gastric Overview</a></li>
<li class="chapter" data-level="32" data-path="gast_superficial.html"><a href="gast_superficial.html"><i class="fa fa-check"></i><b>32</b> Superficial Gastric</a></li>
<li class="chapter" data-level="33" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html"><i class="fa fa-check"></i><b>33</b> Locally-Advanced Gastric</a>
<ul>
<li class="chapter" data-level="33.1" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#preoperative-chemotherapy"><i class="fa fa-check"></i><b>33.1</b> Preoperative Chemotherapy</a></li>
<li class="chapter" data-level="33.2" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#postoperative-chemotherapy"><i class="fa fa-check"></i><b>33.2</b> Postoperative chemotherapy</a></li>
<li class="chapter" data-level="33.3" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#postoperative-chemoradiation-1"><i class="fa fa-check"></i><b>33.3</b> Postoperative chemoradiation</a></li>
<li class="chapter" data-level="33.4" data-path="locally-advanced-gastric.html"><a href="locally-advanced-gastric.html#preoperative-chemoradiation"><i class="fa fa-check"></i><b>33.4</b> Preoperative chemoradiation</a></li>
</ul></li>
<li class="chapter" data-level="34" data-path="hereditary-diffuse-gastric-cancer.html"><a href="hereditary-diffuse-gastric-cancer.html"><i class="fa fa-check"></i><b>34</b> Hereditary Diffuse Gastric Cancer</a></li>
<li class="part"><span><b>Colon Cancer</b></span></li>
<li class="chapter" data-level="35" data-path="colorectal-overview.html"><a href="colorectal-overview.html"><i class="fa fa-check"></i><b>35</b> Colorectal Overview</a></li>
<li class="chapter" data-level="36" data-path="colon-cancer-staging.html"><a href="colon-cancer-staging.html"><i class="fa fa-check"></i><b>36</b> Colon Cancer Staging</a>
<ul>
<li class="chapter" data-level="36.1" data-path="colon-cancer-staging.html"><a href="colon-cancer-staging.html#cea-level"><i class="fa fa-check"></i><b>36.1</b> CEA level</a></li>
<li class="chapter" data-level="36.2" data-path="colon-cancer-staging.html"><a href="colon-cancer-staging.html#ct-scan"><i class="fa fa-check"></i><b>36.2</b> CT Scan</a></li>
<li class="chapter" data-level="36.3" data-path="colon-cancer-staging.html"><a href="colon-cancer-staging.html#pet-scan"><i class="fa fa-check"></i><b>36.3</b> PET scan</a>
<ul>
<li class="chapter" data-level="36.3.1" data-path="colon-cancer-staging.html"><a href="colon-cancer-staging.html#indications-for-pet-in-colorectal-cancer"><i class="fa fa-check"></i><b>36.3.1</b> Indications for PET in colorectal cancer:</a></li>
</ul></li>
<li class="chapter" data-level="36.4" data-path="colon-cancer-staging.html"><a href="colon-cancer-staging.html#adjuvant-therapy"><i class="fa fa-check"></i><b>36.4</b> Adjuvant Therapy</a></li>
</ul></li>
<li class="chapter" data-level="37" data-path="stage-iv-colon-cancer.html"><a href="stage-iv-colon-cancer.html"><i class="fa fa-check"></i><b>37</b> Stage IV Colon Cancer</a>
<ul>
<li class="chapter" data-level="37.1" data-path="stage-iv-colon-cancer.html"><a href="stage-iv-colon-cancer.html#carcinomatosis"><i class="fa fa-check"></i><b>37.1</b> Carcinomatosis</a></li>
<li class="chapter" data-level="37.2" data-path="stage-iv-colon-cancer.html"><a href="stage-iv-colon-cancer.html#colon-resection-in-stage-iv-colon-cancer"><i class="fa fa-check"></i><b>37.2</b> Colon resection in stage IV colon cancer</a></li>
<li class="chapter" data-level="37.3" data-path="stage-iv-colon-cancer.html"><a href="stage-iv-colon-cancer.html#immunotherapy-for-dmmr-msi-high"><i class="fa fa-check"></i><b>37.3</b> Immunotherapy for dMMR (MSI high)</a></li>
</ul></li>
<li class="chapter" data-level="38" data-path="colectomy-1.html"><a href="colectomy-1.html"><i class="fa fa-check"></i><b>38</b> Colectomy</a>
<ul>
<li class="chapter" data-level="38.1" data-path="colectomy-1.html"><a href="colectomy-1.html#extended-node-dissection"><i class="fa fa-check"></i><b>38.1</b> Extended Node dissection</a></li>
</ul></li>
<li class="chapter" data-level="39" data-path="chemotherapy.html"><a href="chemotherapy.html"><i class="fa fa-check"></i><b>39</b> Chemotherapy</a>
<ul>
<li class="chapter" data-level="39.1" data-path="chemotherapy.html"><a href="chemotherapy.html#neoadjuvant-chemotherapy"><i class="fa fa-check"></i><b>39.1</b> Neoadjuvant Chemotherapy</a></li>
</ul></li>
<li class="part"><span><b>Rectal Cancer</b></span></li>
<li class="chapter" data-level="40" data-path="rectal-overview.html"><a href="rectal-overview.html"><i class="fa fa-check"></i><b>40</b> Rectal Overview</a></li>
<li class="chapter" data-level="41" data-path="rectal-cancer-staging.html"><a href="rectal-cancer-staging.html"><i class="fa fa-check"></i><b>41</b> Rectal Cancer Staging</a>
<ul>
<li class="chapter" data-level="41.1" data-path="rectal-cancer-staging.html"><a href="rectal-cancer-staging.html#mri-staging"><i class="fa fa-check"></i><b>41.1</b> MRI staging</a></li>
</ul></li>
<li class="chapter" data-level="42" data-path="rectal-cancer-surgery.html"><a href="rectal-cancer-surgery.html"><i class="fa fa-check"></i><b>42</b> Rectal Cancer Surgery</a></li>
<li class="chapter" data-level="43" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html"><i class="fa fa-check"></i><b>43</b> Rectal Adjuvant Therapy</a>
<ul>
<li class="chapter" data-level="43.0.1" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#short-course-preoperative-therapy"><i class="fa fa-check"></i><b>43.0.1</b> Short-course preoperative therapy</a></li>
<li class="chapter" data-level="43.0.2" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#total-neoadjuvant-therapy"><i class="fa fa-check"></i><b>43.0.2</b> Total Neoadjuvant therapy</a></li>
<li class="chapter" data-level="43.1" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#neoadjuvant-immunotherapy-msi-high"><i class="fa fa-check"></i><b>43.1</b> Neoadjuvant immunotherapy (MSI high)</a></li>
<li class="chapter" data-level="43.2" data-path="rectal-adjuvant-therapy.html"><a href="rectal-adjuvant-therapy.html#non-operative-management-of-rectal-cancer"><i class="fa fa-check"></i><b>43.2</b> Non-operative management of Rectal Cancer</a></li>
</ul></li>
<li class="part"><span><b>Sarcoma</b></span></li>
<li class="chapter" data-level="44" data-path="soft-tissue-sarcomas.html"><a href="soft-tissue-sarcomas.html"><i class="fa fa-check"></i><b>44</b> Soft Tissue Sarcomas</a>
<ul>
<li class="chapter" data-level="44.1" data-path="soft-tissue-sarcomas.html"><a href="soft-tissue-sarcomas.html#desmoid-tumors"><i class="fa fa-check"></i><b>44.1</b> Desmoid Tumors</a></li>
<li class="chapter" data-level="44.2" data-path="soft-tissue-sarcomas.html"><a href="soft-tissue-sarcomas.html#retroperitoneal"><i class="fa fa-check"></i><b>44.2</b> Retroperitoneal</a></li>
<li class="chapter" data-level="44.3" data-path="soft-tissue-sarcomas.html"><a href="soft-tissue-sarcomas.html#peritoneal-mesothelioma"><i class="fa fa-check"></i><b>44.3</b> Peritoneal mesothelioma</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="mailto:jonathan.salo@atriumhealth.org">Feedback and Updates</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">GI Surgical Oncology</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="rectal-adjuvant-therapy" class="section level1 hasAnchor" number="43">
<h1><span class="header-section-number">43</span> Rectal Adjuvant Therapy<a href="rectal-adjuvant-therapy.html#rectal-adjuvant-therapy" class="anchor-section" aria-label="Anchor link to header"></a></h1>
<p>German Rectal Cancer Study (AIO-94) compared preop and postop chemoradiation in locally-advanced rectal cancer <span class="citation">(<a href="#ref-sauer173" role="doc-biblioref">Sauer et al. 2001</a>)</span>. Among 823 patients, local recurrence was 6% in the preoperative group vs 13% in the postop group (p=0.0006). Overall survival was not different, but preop chemoradiation was less toxic. Pathologic complete response rate in the preoperative group as 8%.</p>
<p>NSABP R-03 clinical trial <span class="citation">(<a href="#ref-roh5124" role="doc-biblioref">Roh et al. 2009</a>)</span> randomized 267 patients with T3 or T4 or node-positive rectal cancer to preop vs postop chemoradiation. Disease-free survival was better in the preoperative group, wiht no difference in overall survival. Pathologic complete response rate in the preop group was 15%.</p>
<p>Dutch Rectal Cancer Trial (CKVO 95-04): Demostrated the benefit of preop radiation in combination with TME<span class="citation">(<a href="#ref-kapiteijn638" role="doc-biblioref">Kapiteijn et al. 2001</a>)</span>. Radiation reduced local recurrence form 10.9% to 5.6%</p>
<div id="short-course-preoperative-therapy" class="section level3 hasAnchor" number="43.0.1">
<h3><span class="header-section-number">43.0.1</span> Short-course preoperative therapy<a href="rectal-adjuvant-therapy.html#short-course-preoperative-therapy" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Swedish Rectal Cancer Trial compared surgery alone with preoperative short-course therapy consisting of 500cGy of radiation without chemotherapy administered in one week prior to surgery. Local recurrence was 9% in the therapy group vs 26% in the control group, with an improvement in overall survival of 38% vs 80%<span class="citation">(<a href="#ref-swedishrectalcancertrial980" role="doc-biblioref">Swedish Rectal Cancer Trial et al. 1997</a>)</span>. Of note, this trial was performed in the era prioro to the widespread use of total mesorectal excision.</p>
<p>Stockholm III trial showed that short-course radiation therapy performed 4-8 weeks prior to surgery resulted in imporved rates of pathologic complete response (12% vs 2%) compared with short-course radiation therapy performed the week prior to surgery <span class="citation">(<a href="#ref-pettersson972" role="doc-biblioref">Pettersson et al. 2015</a>)</span></p>
<p>The Dutch trial found a reduction in local recurrence form 10.9% to 5.6% with preoperative radiation with no difference in survival<span class="citation">(<a href="#ref-kapiteijn638" role="doc-biblioref">Kapiteijn et al. 2001</a>)</span>. A later update<span class="citation">(<a href="#ref-vangijn575" role="doc-biblioref">van Gijn et al. 2011</a>)</span> The Medical Research Council C07 trial compared preoperative short-course radiation with selective post-operative chemoradiation and found no difference in local recurrence (4.4% vs 10.6%) and no difference in overall survival.<span class="citation">(<a href="#ref-sebag-montefiore811" role="doc-biblioref">Sebag-Montefiore et al. 2009</a>)</span></p>
</div>
<div id="total-neoadjuvant-therapy" class="section level3 hasAnchor" number="43.0.2">
<h3><span class="header-section-number">43.0.2</span> Total Neoadjuvant therapy<a href="rectal-adjuvant-therapy.html#total-neoadjuvant-therapy" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>RAPIDO trial randomized 920 patients with T4 or node-positive disease to long-course chemoradiation followed by surgery vs short-course radiation followed by chemotherapy and surgery. The pCR rate was significantly higher in the short course/chemotherapy/surgery group (28% vs 14%) and disease-specific surival at 3years was higher (30% vs 24%).<span class="citation">(<a href="#ref-bahadoer29" role="doc-biblioref">Bahadoer et al. 2021</a>)</span> <span class="citation">(<a href="#ref-vandervalk75" role="doc-biblioref">van der Valk et al. 2020</a>)</span></p>
<p>PRODIGE 23 randomized 461 patients with T3 or T4 recta cancers to long-course radiation followed by surgery vs induction chemotherapy, long-course radiation followed by surgery. Up-front chemotherapy was associates with increased 3-year survival (76% vs 69%) and an increase in rate of pathologic complete response of 28% vs 12%.<span class="citation">(<a href="#ref-conroy702" role="doc-biblioref">Conroy et al. 2021</a>)</span></p>
<p>STELLAR trial <span class="citation">(<a href="#ref-jin1681" role="doc-biblioref">Jin et al. 2022</a>)</span> TNT with short-course radiation (5Gy x 5 days) + CAPEOX chemotherapy vs long-course chemoRT with capecitibine. No differences in relapse-free survival or metastasis free survival. Overall survival better with TNT (p=0.03). On subgroup analysis, no group appeared to have more benefit. pCR rate 17% with TNT vs 13.9% with conventional chemoradiation. Positive margins (R1) occurred in 8.5% of TNT patients vs 12.5% in the conventional chemoRT group.</p>
<p>OPRA clinical trial <span class="citation">(<a href="#ref-garcia-aguilarJCO2200032" role="doc-biblioref">Garcia-Aguilar et al. 2022</a>)</span>. 324 rectal cancer patients staged with MRI randomized to INCT (induction chemo followed by chemoRT) vs CNCT (Chemoradiation followed by chemotherapy). Patients with a resopnse were offered watch and wait. Patients without a response were treated with surgery. No difference in disease-free survival or overall survival. Among patients in watch and wait, somewhat more patients with INCT had recurrences (42 patients vs 32 patients). More organ preservation with CNCT. See also <span class="citation">(<a href="#ref-smith767" role="doc-biblioref">Smith et al. 2015</a>)</span></p>
</div>
<div id="neoadjuvant-immunotherapy-msi-high" class="section level2 hasAnchor" number="43.1">
<h2><span class="header-section-number">43.1</span> Neoadjuvant immunotherapy (MSI high)<a href="rectal-adjuvant-therapy.html#neoadjuvant-immunotherapy-msi-high" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>MSKCC trial of neoadjuvant PD-1 blockade with 6 months of dostarlimab for 12 patients with MMR-deficient (MSI-high) rectal cancer resulted in 100% clinical response rate <span class="citation">(<a href="#ref-cercek2363" role="doc-biblioref">Cercek et al. 2022</a>)</span>. No patients were subsequently treated with either chemoradiation or surgery as originally planned.</p>
<p>PICC trial <span class="citation">(<a href="#ref-hu38" role="doc-biblioref">Hu et al. 2022</a>)</span> Chinese trial of PD-1 blockade with neoadjvant toripalimab + colecoxib vs toripalimab for 3 months in 34 patients with MMR-deficient locally-advanced (T3/4 or N+) colorectal cancer. All patients were then treated with surgery. Pathologic complete response in 88% of dual-therapy patients and 65% of monotherapy. Grade 3 toxicity in 1/34 patients. Previous neoadjuvant chemo in 25%. Rectal cancer in 18%.</p>
</div>
<div id="non-operative-management-of-rectal-cancer" class="section level2 hasAnchor" number="43.2">
<h2><span class="header-section-number">43.2</span> Non-operative management of Rectal Cancer<a href="rectal-adjuvant-therapy.html#non-operative-management-of-rectal-cancer" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>MSKCC published an experience of 113 patients with cCR after chemoradiation for rectal cancer who elected non-operative management <span class="citation">(<a href="#ref-smithe185896" role="doc-biblioref">Smith et al. 2019</a>)</span>. Among this group, 22 developed a local recurrence, and 8% developed metastatic disease.<span class="citation">(<a href="#ref-smith657" role="doc-biblioref">Smith, Paty, and Garcia-Aguilar 2020</a>)</span></p>

</div>
</div>



<h3>References</h3>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-bahadoer29" class="csl-entry">
Bahadoer, Renu R., Esmée A. Dijkstra, Boudewijn van Etten, Corrie A. M. Marijnen, Hein Putter, Elma Meershoek-Klein Kranenbarg, Annet G. H. Roodvoets, et al. 2021. <span>“Short-Course Radiotherapy Followed by Chemotherapy Before Total Mesorectal Excision (<span>TME</span>) Versus Preoperative Chemoradiotherapy, <span>TME</span>, and Optional Adjuvant Chemotherapy in Locally Advanced Rectal Cancer (<span>RAPIDO</span>): A Randomised, Open-Label, Phase 3 Trial.”</span> <em>The Lancet. Oncology</em> 22 (1): 29–42. <a href="https://doi.org/10.1016/S1470-2045(20)30555-6">https://doi.org/10.1016/S1470-2045(20)30555-6</a>.
</div>
<div id="ref-cercek2363" class="csl-entry">
Cercek, Andrea, Melissa Lumish, Jenna Sinopoli, Jill Weiss, Jinru Shia, Michelle Lamendola-Essel, Imane H. El Dika, et al. 2022. <span>“<span>PD-1 Blockade</span> in <span>Mismatch Repair-Deficient</span>, <span>Locally Advanced Rectal Cancer</span>.”</span> <em>The New England Journal of Medicine</em> 386 (25): 2363–76. <a href="https://doi.org/10.1056/NEJMoa2201445">https://doi.org/10.1056/NEJMoa2201445</a>.
</div>
<div id="ref-conroy702" class="csl-entry">
Conroy, Thierry, Jean-François Bosset, Pierre-Luc Etienne, Emmanuel Rio, Éric François, Nathalie Mesgouez-Nebout, Véronique Vendrely, et al. 2021. <span>“Neoadjuvant Chemotherapy with <span>FOLFIRINOX</span> and Preoperative Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer (<span>UNICANCER-PRODIGE</span> 23): A Multicentre, Randomised, Open-Label, Phase 3 Trial.”</span> <em>The Lancet. Oncology</em> 22 (5): 702–15. <a href="https://doi.org/10.1016/S1470-2045(21)00079-6">https://doi.org/10.1016/S1470-2045(21)00079-6</a>.
</div>
<div id="ref-garcia-aguilarJCO2200032" class="csl-entry">
Garcia-Aguilar, Julio, Sujata Patil, Marc J. Gollub, Jin K. Kim, Jonathan B. Yuval, Hannah M. Thompson, Floris S. Verheij, et al. 2022. <span>“Organ <span>Preservation</span> in <span>Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy</span>.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em>, April, JCO2200032. <a href="https://doi.org/10.1200/JCO.22.00032">https://doi.org/10.1200/JCO.22.00032</a>.
</div>
<div id="ref-hu38" class="csl-entry">
Hu, Huabin, Liang Kang, Jianwei Zhang, Zehua Wu, Hui Wang, Meijin Huang, Ping Lan, et al. 2022. <span>“Neoadjuvant <span>PD-1</span> Blockade with Toripalimab, with or Without Celecoxib, in Mismatch Repair-Deficient or Microsatellite Instability-High, Locally Advanced, Colorectal Cancer (<span>PICC</span>): A Single-Centre, Parallel-Group, Non-Comparative, Randomised, Phase 2 Trial.”</span> <em>The Lancet. Gastroenterology &amp; Hepatology</em> 7 (1): 38–48. <a href="https://doi.org/10.1016/S2468-1253(21)00348-4">https://doi.org/10.1016/S2468-1253(21)00348-4</a>.
</div>
<div id="ref-jin1681" class="csl-entry">
Jin, Jing, Yuan Tang, Chen Hu, Li-Ming Jiang, Jun Jiang, Ning Li, Wen-Yang Liu, et al. 2022. <span>“Multicenter, <span>Randomized</span>, <span>Phase III Trial</span> of <span>Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy</span> in <span>Locally Advanced Rectal Cancer</span> (<span>STELLAR</span>).”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 40 (15): 1681–92. <a href="https://doi.org/10.1200/JCO.21.01667">https://doi.org/10.1200/JCO.21.01667</a>.
</div>
<div id="ref-kapiteijn638" class="csl-entry">
Kapiteijn, E., C. A. Marijnen, I. D. Nagtegaal, H. Putter, W. H. Steup, T. Wiggers, H. J. Rutten, et al. 2001. <span>“Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer.”</span> <em>The New England Journal of Medicine</em> 345 (9): 638–46. <a href="https://doi.org/10.1056/NEJMoa010580">https://doi.org/10.1056/NEJMoa010580</a>.
</div>
<div id="ref-pettersson972" class="csl-entry">
Pettersson, D., E. Lörinc, T. Holm, H. Iversen, B. Cedermark, B. Glimelius, and A. Martling. 2015. <span>“Tumour Regression in the Randomized <span>Stockholm III Trial</span> of Radiotherapy Regimens for Rectal Cancer.”</span> <em>The British Journal of Surgery</em> 102 (8): 972–978; discussion 978. <a href="https://doi.org/10.1002/bjs.9811">https://doi.org/10.1002/bjs.9811</a>.
</div>
<div id="ref-roh5124" class="csl-entry">
Roh, Mark S., Linda H. Colangelo, Michael J. O’Connell, Greg Yothers, Melvin Deutsch, Carmen J. Allegra, Morton S. Kahlenberg, et al. 2009. <span>“Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients with Carcinoma of the Rectum: <span>NSABP R-03</span>.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 27 (31): 5124–30. <a href="https://doi.org/10.1200/JCO.2009.22.0467">https://doi.org/10.1200/JCO.2009.22.0467</a>.
</div>
<div id="ref-sauer173" class="csl-entry">
Sauer, R., R. Fietkau, C. Wittekind, P. Martus, C. Rödel, W. Hohenberger, G. Jatzko, et al. 2001. <span>“Adjuvant Versus Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer. <span>A</span> Progress Report of a Phase-<span>III</span> Randomized Trial (Protocol <span>CAO</span>/<span>ARO</span>/<span>AIO-94</span>).”</span> <em>Strahlentherapie Und Onkologie: Organ Der Deutschen Rontgengesellschaft ... [Et Al]</em> 177 (4): 173–81. <a href="https://doi.org/10.1007/pl00002396">https://doi.org/10.1007/pl00002396</a>.
</div>
<div id="ref-sebag-montefiore811" class="csl-entry">
Sebag-Montefiore, David, Richard J. Stephens, Robert Steele, John Monson, Robert Grieve, Subhash Khanna, Phil Quirke, et al. 2009. <span>“Preoperative Radiotherapy Versus Selective Postoperative Chemoradiotherapy in Patients with Rectal Cancer (<span>MRC Cr07</span> and <span>NCIC-CTG C016</span>): A Multicentre, Randomised Trial.”</span> <em>The Lancet</em> 373 (9666): 811–20. <a href="https://doi.org/10.1016/S0140-6736(09)60484-0">https://doi.org/10.1016/S0140-6736(09)60484-0</a>.
</div>
<div id="ref-smith767" class="csl-entry">
Smith, J. Joshua, Oliver S. Chow, Marc J. Gollub, Garrett M. Nash, Larissa K. Temple, Martin R. Weiser, José G. Guillem, et al. 2015. <span>“Organ <span>Preservation</span> in <span>Rectal Adenocarcinoma</span>: A Phase <span>II</span> Randomized Controlled Trial Evaluating 3-Year Disease-Free Survival in Patients with Locally Advanced Rectal Cancer Treated with Chemoradiation Plus Induction or Consolidation Chemotherapy, and Total Mesorectal Excision or Nonoperative Management.”</span> <em>BMC Cancer</em> 15 (October): 767. <a href="https://doi.org/10.1186/s12885-015-1632-z">https://doi.org/10.1186/s12885-015-1632-z</a>.
</div>
<div id="ref-smith657" class="csl-entry">
Smith, J. Joshua, Philip B. Paty, and Julio Garcia-Aguilar. 2020. <span>“Watch and <span>Wait</span> in <span>Rectal Cancer</span> or <span>More Wait</span> and <span>See</span>?”</span> <em>JAMA Surgery</em> 155 (7): 657–58. <a href="https://doi.org/10.1001/jamasurg.2020.0226">https://doi.org/10.1001/jamasurg.2020.0226</a>.
</div>
<div id="ref-smithe185896" class="csl-entry">
Smith, J. Joshua, Paul Strombom, Oliver S. Chow, Campbell S. Roxburgh, Patricio Lynn, Anne Eaton, Maria Widmar, et al. 2019. <span>“Assessment of a <span class="nocase">Watch-and-Wait Strategy</span> for <span>Rectal Cancer</span> in <span>Patients With</span> a <span>Complete Response After Neoadjuvant Therapy</span>.”</span> <em>JAMA Oncology</em> 5 (4): e185896. <a href="https://doi.org/10.1001/jamaoncol.2018.5896">https://doi.org/10.1001/jamaoncol.2018.5896</a>.
</div>
<div id="ref-swedishrectalcancertrial980" class="csl-entry">
Swedish Rectal Cancer Trial, B. Cedermark, M. Dahlberg, B. Glimelius, L. Påhlman, L. E. Rutqvist, and N. Wilking. 1997. <span>“Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer.”</span> <em>The New England Journal of Medicine</em> 336 (14): 980–87. <a href="https://doi.org/10.1056/NEJM199704033361402">https://doi.org/10.1056/NEJM199704033361402</a>.
</div>
<div id="ref-vandervalk75" class="csl-entry">
van der Valk, Maxime J. M., Corrie A. M. Marijnen, Boudewijn van Etten, Esmée A. Dijkstra, Denise E. Hilling, Elma Meershoek-Klein Kranenbarg, Hein Putter, et al. 2020. <span>“Compliance and Tolerability of Short-Course Radiotherapy Followed by Preoperative Chemotherapy and Surgery for High-Risk Rectal Cancer - <span>Results</span> of the International Randomized <span class="nocase">RAPIDO-trial</span>.”</span> <em>Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology</em> 147 (June): 75–83. <a href="https://doi.org/10.1016/j.radonc.2020.03.011">https://doi.org/10.1016/j.radonc.2020.03.011</a>.
</div>
<div id="ref-vangijn575" class="csl-entry">
van Gijn, Willem, Corrie A. M. Marijnen, Iris D. Nagtegaal, Elma Meershoek-Klein Kranenbarg, Hein Putter, Theo Wiggers, Harm J. T. Rutten, et al. 2011. <span>“Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer: 12-Year Follow-up of the Multicentre, Randomised Controlled <span>TME</span> Trial.”</span> <em>The Lancet. Oncology</em> 12 (6): 575–82. <a href="https://doi.org/10.1016/S1470-2045(11)70097-3">https://doi.org/10.1016/S1470-2045(11)70097-3</a>.
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="rectal-cancer-surgery.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="soft-tissue-sarcomas.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/jcsalo/gi_surgonc/edit/main/77-rectal_RT.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["gi_surgonc.pdf", "gi_surgonc.epub"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true,
"search": true,
"sharing": false
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.9/latest.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
